Ratings
0
Nobody has rated this yet. Be the first!
Works
3
CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner
Vemurafenib cooperates with HPV to promote initiation of cutaneous tumors
Patient-reported outcomes in KEYNOTE-006, a randomised study of pembrolizumab versus ipilimumab in patients with advanced melanoma
